New Heart Drug From Novartis: Will It Raise The Risk of Alzheimer’s Disease?
LCZ696 is a heart failure drug from Novartis that many observers think will gain FDA approval later this year and go on to become a blockbuster. Perhaps the biggest obstacle to the drug’s [...]